C000217776 Performance — Fidelity Disruptive Medicine Fund
Data updated: 2023-08-03
C000217776 returned +10.34% over one year to May 2023. The annualised 3-year return is +0.35%. Against its International Thematic Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $101, against $113 for the category, and to $110 over one year, against $100. Volatility over the past three years was 17.66% a year. In the 12 months to May 2023 the fund lost a net $13.8M, and assets reached $43.22M.
C000217776 Growth of $100
What $100 invested in Fidelity Disruptive Medicine Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Thematic Equity category average over the same months.
| Period | C000217776 | Category average |
|---|---|---|
| 1 year (Jun 2022 – May 2023) | $110 | $100 |
| 3 years (Jun 2020 – May 2023) | $101 | $113 |
| Since data start (May 2020 – May 2023) | $108 | $120 |
C000217776 Trailing Returns
Total returns to May 2023, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +10.34% |
| 3 years (annualised) | +0.35% |
C000217776 Annual Returns
Calendar-year total returns of Fidelity Disruptive Medicine Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2023 (Jan–May) | +1.95% |
| 2022 | −21.70% |
| 2021 | +10.99% |
| 2020 (May–Dec) | +22.14% |
C000217776 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +4.4% | −4.8% | +2.6% | +3.3% | −3.2% | — | — | — | — | — | — | — |
| 2022 | −14.7% | −1.0% | +2.5% | −12.6% | −4.3% | +0.2% | +8.6% | −1.9% | −5.0% | +5.5% | +5.1% | −3.8% |
| 2021 | +1.8% | −0.4% | −1.4% | +6.6% | −2.5% | +5.1% | +1.7% | +3.3% | −3.8% | +5.4% | −7.0% | +2.7% |
| 2020 | — | — | — | — | +7.1% | +1.2% | +4.6% | +1.3% | −0.6% | −2.0% | +4.9% | +4.2% |
C000217776 Risk
Risk measures from monthly returns over Jun 2020 – May 2023.
- 3-year volatility (annualised): 17.66%
- 3-year Sharpe ratio: -0.23 (vs 4.5% risk-free rate)
- Best month: +8.62% (Jul 2022)
- Worst month: −14.74% (Jan 2022)
C000217776 Fund Flows
Monthly money in and out of Fidelity Disruptive Medicine Fund, from SEC Form N-PORT.
- 12-month net flow: −$13.8M
- 12-month gross sales (incl. reinvestments): $54.7M
- Sales ÷ redemptions: 0.80×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2023 | $41.3M | $41.6M | −$371K |
| Apr 2023 | $2.1M | $817K | $1.3M |
| Mar 2023 | $589K | $1.5M | −$877K |
| Feb 2023 | $500K | $1.4M | −$892K |
| Jan 2023 | $684K | $1.6M | −$912K |
| Dec 2022 | $680K | $3.5M | −$2.8M |
| Nov 2022 | $867K | $1.5M | −$592K |
| Oct 2022 | $760K | $8.1M | −$7.4M |
| Sep 2022 | $751K | $2.0M | −$1.3M |
| Aug 2022 | $2.2M | $2.6M | −$378K |
| Jul 2022 | $2.7M | $1.8M | $937K |
| Jun 2022 | $1.5M | $2.2M | −$629K |
C000217776 Assets Under Management
Net assets of Fidelity Disruptive Medicine Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2023-05-31 | $43.22M |
| 2023-02-28 | $42.07M |
| 2022-11-30 | $48.64M |
| 2022-08-31 | $55.82M |
| 2022-05-31 | $52.35M |
| 2022-02-28 | $66.94M |
| 2021-11-30 | $80.33M |
| 2021-08-31 | $82.18M |
| 2021-05-31 | $68.18M |
| 2021-02-28 | $63.60M |
| 2020-11-30 | $41.69M |
| 2020-08-31 | $26.20M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.